![]() Yale University Dept. of Psychiatry 300 George Street New Haven, CT 06511 USA Tel: 203-785-2117 ![]() |
Department of Psychiatry Faculty
EducationB.A., 1992, Skidmore College Research InterestOur goal is to establish an understanding of the molecular and neuronal circuits that are responsible for controlling reward-related behavior. We are particularly interested in defining brain mechanisms that regulate eating and are important in the development of obesity. Moreover, we hypothesize that dysfunction of these appetitive circuits also contributes to pathological states, such as eating disorders, drug addiction, and depression. As a first step toward understanding the molecular changes that give rise to excessive consumption or restriction, we seek to identify the molecules and neural circuitry that connect initial metabolic signals to behavioral output. While the hypothalamus is critical for receiving metabolic signals, how these initial signaling events result in altered behavior remains unknown. Current projects in the lab are aimed at defining the molecular circuits that integrate the hypothalamus and peripheral metabolic signals with brain reward centers. In addition, the lab is active in developing genetic and molecular tools that facilitate our efforts to better understand the molecular and cellular basis of neural plasticity and animal behavior. For example, our laboratory has pioneered the use of viral-mediated RNAi to create gene knockdowns in the brain. We will continue to develop powerful new techniques to better connect genes, neural anatomy and animal behavior. Graduate School (Biological & Biomedical Sciences) web page Laboratory personnel:Douglas Guarnieri, Ph.D., Associate Research Scientist Publications of NoteSharf, R., Sarhan, M., and R.J. DiLeone (2008) Orexin mediates expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biological Psychiatry, 64(3): 175-83. Graham, D.L., Edwards, S., Bachtell, R.K., DiLeone, R.J., Rios, M., and D.W. Self (2007) Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nature Neuroscience, 10(8):1029-37. Trinko, R., Sears, R.M., Guarnieri, D.J., and R.J. DiLeone (2007) Neural mechanisms underlying obesity and drug addiction. Physiology and Behavior, 91(5): 499-505. Hommel, J.D., Trinko, R., Sears, R.M., Georgescu, D., Liu, Z.W., Gao, X.B., Thurmon, J.J., Marinelli, M., and R.J. DiLeone (2006) Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron, 51(6): 801-810. de Lecea, L., Jones, B.E., Boutrel, B., Borgland, S.L., Nishino, S., Bubser, M., and R.J. DiLeone (2006) Addiction and arousal: alternative roles of hypothalamic peptides. Journal of Neuroscience, 26(41): 10372-10375. Berton, O., McClung, C.A., DiLeone, R.J., Krishnan, V., Renthal, W., Russo, S.J., Graham, D., Tsankova, N.M., Bolanos, C.A., Rios, M., Monteggia, L.M., Self, D.W., and E.J. Nestler (2006) Essential role of BDNF in dopaminergic reward regions in social defeat stress. Science, 311(5762): 864-868. Zachariou, V., Bolanos, C.A., Selley, D.E., Theobald, D., Cassidy, M. P., Kelz, M.B., Shaw-Lutchman, T., Berton, O., Sim-Selley, L.J., DiLeone, R.J., Kumar, A., and E.J. Nestler. (2006) An essential role for ?FosB in the nucleus accumbens in morphine action. Nature Neuroscience, 9(2): 205-211. Georgescu, D., Sears, R.M., Hommel, J.D, Barrot, M., Bolaņos, C.A., Marsh, D.J., Bednarek, M.A., Bibb, J.A., Maratos-Flier E., Nestler, E.J., and R.J. DiLeone (2005) The hypothalamic neuropeptide MCH acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. Journal of Neuroscience 25(11): 2933-2940. Hommel, J.D., Sears, R.M., Georgescu, D., Simmons, D.L., and R. J. DiLeone (2003) Local gene knockdown in the brain using viral-mediated RNA interference. Nature Medicine 9(12): 1539-1544. Georgescu, D., Zachariou, V., Barrot, M., Mieda, M., Willie, J.T., Eisch, A.J., Yanagisawa, M., Nestler, E.J., and R.J. DiLeone (2003) Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. Journal of Neuroscience 23(8): 3106-3111. DiLeone, R.J., Georgescu, D., and E.J. Nestler (2003). Lateral hypothalamic peptides and drug addiction. Life Sciences 73:759-768. Zachariou, V., Georgescu, D., Sanchez, N., Rahman, Z., DiLeone, R., Berton, O., Neve, R.L., Sim-Selley, L.J., Selley, D.E., Gold, S.J., and E.J. Nestler (2003) Essential role for RGS9 in opiate action. Proceedings of the National Academy of Sciences 100 (23): 13656-61. Rahman, Z., Schwarz, J., Gold, S.J., Zachariou, V., Wein M.N., Choi, K.H., Kovoor, A., Chen C.K., DiLeone, R.J., Schwarz, S.C., Selley D.E., Sim-Selley, L.J., Barrot, M., Luedtke, R.R., Self, D., Neve, R.L., Lester, H.A., Simon, M.I., and E.J. Nestler (2003) RGS9 modulates dopamine signaling in the basal ganglia. Neuron, 38(6): 941-952. Barrot, M., Olivier, J.D.A., Perrotti, L.I., DiLeone, R.J., Berton, O., Eisch, A.J., Impey, S., Storm, D.R., Neve, R.L., Yin, J.C., Zachariou, V., and E.J. Nestler (2002) CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proceedings of the National Academy of Sciences 99(17): 11435-11440. Nestler, E.J., Barrot, M., DiLeone, R.J., Eisch, A.J., Gold, S.J., and L.M. Monteggia (2002). Neurobiology of Depression. Neuron 34(1): 13-25.
Last modified:
April 17, 2009
|